United States securities and exchange commission logo





                              September 19, 2022

       Rohan Ajila
       Chief Executive Officer
       Global Consumer Acquisition Corp
       1926 Rand Ridge Court
       Marietta, GA, 30062

                                                        Re: Global Consumer
Acquisition Corp
                                                            Amendment No. 5 to
Preliminary Proxy on Schedule 14A
                                                            Filed August 26,
2022
                                                            File No. 001-40468

       Dear Mr. Ajila:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

            After reviewing your response and any amendment you may file in
response to these
       comments, we may have additional comments.

       Preliminary Proxy on Schedule 14A filed August 26, 2022

       Questions and Answers About the Proposals, page 4

   1.                                                   We note your response
to prior comment one, and reissue in part. Please include mention
                                                        that the financing
transactions are non-binding proposals, and that assuming a maximum
                                                        redemption scenario,
GACQ would not have the ability to fund the acquisitions.
                                                        Highlight this
information in a separate question and answer.
       Summary of this Proxy Statement
       Parties to the Buisness Combinations
       GP Global, page 20

   2.                                                   Please provide updated
financial disclosures related to GP Global here and in risk factors,
                                                        to the extent
applicable.
 Rohan Ajila
Global Consumer Acquisition Corp
September 19, 2022
Page 2
The GP Global Stock Purchase Agreement
Anticipated Accounting Treatment , page 28

3.       Please revise the disclosures related to the anticipated accounting
treatment for the
         acquisition of GP Global, under both the minimum and maximum
redemption scenarios,
         to be consistent with the disclosures on page 172.
Proposed Financing Transaction in Connection with the Business Combination,
page 34

4.       We note your response to prior 2. As previously requested, please
revise the Proxy
         Statement to prominently explain and disclose the following:
             The reasons why you have been unable to obtain definitive
financing for the
             acquisitions to date;
             The reasons why you intend to proceed with shareholder votes
seeking approval for
             each acquisition prior to obtaining definitive financing;
             Whether the proposed financing transaction represents the full
range of potential
             financing sources;
             The fact that shareholders will not have an opportunity to change
their votes related
             to the acquisitions or to approve any alternative financing
agreements that are entered
             into; and
             The potential risks and consequences to shareholders of voting to
approve the
             acquisitions without knowing how they will they will be financed.
Unaudited Pro Forma Condensed Combined Financial Information, page 90

5.     Based on the current disclosures related to the Luminex Seller
promissory note and the
       proposed financing transaction, please tell us, and consider the need to
revise your
       disclosures to explain, these aspects of the transaction economics:
           Due to the fact that the Luminex acquisition is conditioned on the
Company entering
            into definitive agreements for debt, equity or structured financing
that will generate at
            least $180 Million in cash proceeds, clarify the purpose of the
Luminex Seller
            promissory note and explain when and under what circumstances the
note would be
            issued. In this regard, if the Company receives $180 million in
cash proceeds from
            definitive financing agreements, which your disclosure indicates is
a condition
            precedent to closing the Luminex acquisition, it is not clear why
the Luminex Seller
            promissory note would be necessary; and
           Based on the disclosed terms of the proposed sale leaseback
arrangement, explain
FirstName LastNameRohan
            why a lender wouldAjila
                                 agree to provide cash proceeds of $75 million
in exchange for
Comapany fixed
            NameGlobal    Consumer
                  assets with         Acquisition
                              an estimated         Corpof $53.5 million, as
currently presented in
                                            fair value
            the pro forma
September 19, 2022 Page 2  balance  sheet.
FirstName LastName
 Rohan Ajila
FirstName LastNameRohan    Ajila
Global Consumer  Acquisition Corp
Comapany 19,
September NameGlobal
              2022    Consumer Acquisition Corp
September
Page 3    19, 2022 Page 3
FirstName LastName
6.       We note your responses to prior comments 8 and 9 and the revisions to
your filing. You
         disclose that the acquisition of Luminex is conditioned on the Company
entering into
         definitive agreements for debt, equity or structured financing that
generate at least $180
         Million in cash proceeds and that the Luminex Seller has agreed any
purchase price cash
         shortfall may be paid with a promissory note from the Company. Please
revise your pro
         forma presentation to comply with the requirement in Rule 11-02(a)(10)
of Regulation S-
         X to provide additional pro forma presentations which give effect to
the range of possible
         results. Those presentations should include, but necessarily be
limited to:
             The range of possible terms of the promissory note, including
interest rates;
              maturities; call or put provisions; settlement alternatives,
other than cash; acceleration
              clauses, including whether objective or subjective; and
indexation, if any;
             The range of possible equity issuances and their material terms;
             The range of possible debt financings and their material terms;
             The range of possible structures financings and their material
terms; and
             The    certain conditions    you reference for the potential sale
leaseback transaction.

7.       For each of the items described in the preceding comment, please
revise your pro forma
         notes to comply with Rule 11-02(a)(8) which requires that all pro
forma adjustments be
         referenced to notes that clearly explain the assumptions involved.
Please also ensure your
         pro forma financial statements appropriately reflect the impact of the
related transactions
         in all appropriate periods, in this regard we the pro forma statements
of operations for the
         six months ended June 30, 2022 do not record any interest expense
related to the Luminex
         Seller promissory note.
8.       In regard to the new Bonus share proposal, please revise the pro forma
financial
         statements to address the following:
             Based on your disclosure that the issuance of the bonus shares
will trigger
              adjustments to the exercise price of the outstanding GACQ
warrants as well as to the
              number of shares issuable upon the exercise of the GACQ warrants,
more fully
              explain and quantify the actual impact the issuance of bonus
shares will have on the
              GACQ warrants;
             Disclose how you intend to account for the issuance of the bonus
shares and provide
              to us your supporting accounting analysis;
             Disclose if and how the issuance of the bonus shares will impact
your accounting for
              the GACQ warrants and provide to us your supporting accounting
analysis; and
             To the extent applicable, present the impact of fair value changes
to the GACQ
              warrants that would have resulted if the bonus shares had been
issued on 1/1/21 in the
              annual and interim pro forma statements of operations.
 Rohan Ajila
FirstName LastNameRohan    Ajila
Global Consumer  Acquisition Corp
Comapany 19,
September NameGlobal
              2022    Consumer Acquisition Corp
September
Page 4    19, 2022 Page 4
FirstName LastName
9.       We note you have included Proposal #8, in which you are seeking
shareholder approval to
         modify the current charter provision that requires net tangible assets
to exceed $5 million
         upon the consummation of a Business Combination. Please revise your
pro forma
         disclosure to transparently indicate, if true, that the maximum
redemption scenario
         presented is premised on proposal #8 passing. Please further revise
your pro form
         presentation to depict the results that will occur if proposal #8 does
not pass. Refer to
         Rule 11-02(a)(10) of Regulation S-X.
10.      We note your response to prior comment 6; however, we continue to note
references in
         the filing that indicate GP Global has an equity value of $88 million
and ~8.8 million
         shares will be issued to acquire GP Global, for example, see pages
154, 279 and 280 and,
         potentially, other disclosures related to Mr. Pai.
11.      Refer to note 4(I) on page 109 and note 7(G) on 112 page. We note you
reclassified
         certain revolver debt from current to long-term in the pro forma
balance sheets on pages
         93-94 and 98-99. Please disclose if you have an agreement from the
lenders to extend the
         maturity dates of such debt beyond 12 months of the date of the pro
forma balance sheet.
         If not, it is not clear how you determined the reclassifications are
appropriate. Please
         clarify or revise.
General

12.      We note the "bonus shares" you intend to issue to non-redeeming
shareholders. Please
         revise to clarify the source of the "pool" of shares to be issued and
whether non-redeeming
         shareholders must vote in favor of the proposals. Please also tell us
how the establishment
         of the pool and issuance of shares will be conducted consistent with
Section 5 of the
         Securities Act.
13.      We note the "adjustments" that will result from the issuance of bonus
shares. Please
         describe those adjustments in greater detail. Provide specific
quantified disclosure.
14.      We note that the bonus shares are to be distributed immediately prior
to the consummation
         of the Business Combination. As such, please revise your disclosure in
your disclosure
         regarding the tax consequences to clearly identify and articulate the
tax consequences of
         issuing the bonus shares in connection with the Business Combination.
15.      Please revise to clarify who can receive bonus shares. For example,
will it include your
         affiliates or other insiders who already agreed not to redeem? Also
clarify the timing of
         the bonus share issuance and how the record date is determined.
 Rohan Ajila
FirstName LastNameRohan    Ajila
Global Consumer  Acquisition Corp
Comapany 19,
September NameGlobal
              2022    Consumer Acquisition Corp
September
Page 5    19, 2022 Page 5
FirstName LastName
16.      Where you discuss the bonus shares and establishment of the pool, also
revise to discuss
         the financial interests of your affiliates in encouraging shareholders
not to redeem their
         shares in connection with the transactions. Ensure your disclosure
regarding the bonus
         shares is balanced with, for example, equally prominent disclosure
regarding these
         interests, the uncertainty of the financing and inability to complete
a PIPE financing, and
         recent results of operations and financial condition of the targets,
such as the recent
         financial condition of Luminex.
17.      Regarding Proposal 8, where you include disclosure throughout your
document about
         maximum redemption scenarios, please ensure that such disclosure
assumes that articles
         are amended to lift this cap and consequences if such approval is not
obtained.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

        You may contact Andi Carpenter at 202-551-3645 or Anne McConnell at
202-551-3709
if you have questions regarding comments on the financial statements and
related
matters. Please contact Erin Donahue at 202-551-6063 or Geoffrey Kruczek at
202-551-3641
with any other questions.



                                                               Sincerely,

                                                               Division of
Corporation Finance
                                                               Office of
Manufacturing
cc:      Mitchell Nussbaum